-
Drugs
-
FDA Drug Safety Podcasts by Date
| Epinephrine CFC Metered-dose Inhalers - Questions and Answers | September 25, 2009 | Full Version Run Time: 00:05:52 |
 |
Transcript |
| Questions and Answers About Acetaminophen and Liver Injury for Consumers | July 29, 2009 | Full Version Run Time: 00:09:33 |
|
Transcript |
| The FDA recommends that consumers should not use body building products marketed as containing steroids or steroid-like substances | July 28, 2009 | Full Version Run Time: 00:04:02 |
|
Transcript |
| FDA Requires New Boxed Warnings for the Smoking Cessation Drugs Chantix and Zyban | July 7, 2009 | Full Version Run Time: 00:04:13 |
|
Transcript |
| Loss of Sense of Smell with Intranasal Cold Remedies Containing Zinc | June 16, 2009 | Full Version Run Time: 00:03:40 |
|
Transcript |
| Potential Hazards of Skin Products Containing Numbing Ingredients for Relieving Pain from Mammography and Other Medical Tests and Conditions | January 16, 2009 | Overview Run Time: 00:02:57 |
|
Transcript |
| Full Version Run Time: 00:04:33 |
|
Transcript | ||
| Suicidal Thoughts and Behavior: Antiepileptic Drugs | December 19, 2008 | Overview Run Time: 00:04:21 |
|
Transcript |
| Full Version Run Time: 00:05:18 |
|
Transcript | ||
| FDA's Action Against Marketing Unapproved Drugs | October 17, 2008 | Run Time: 00:13:00 |
|
Transcript |
| Measures undertaken to Address Concerns about Marketing of Unapproved Drugs | October 10, 2008 | Run Time: 00:13:00 |
|
Transcript |
| Updated: Transition from Chlorofluorocarbon (CFC) Propelled Albuterol Inhalers to Hydrofluroalkane (HFA) Propelled Albuterol Inhalers | September 26, 2008 | Full Version Run Time: 00:08:05 |
|
Transcript |
| Transition from Chlorofluorocarbon (CFC) Propelled Albuterol Inhalers to Hydrofluroalkane (HFA) Propelled Albuterol Inhalers | May 30, 2008 | Overview Run Time: 00:03:06 |
|
Transcript |
| Full Version Run Time: 00:04:02 |
|
Transcript | ||
| Important Information for the Safe Use of Tussionex Pennkinetic Extended-Release Suspension | March 13, 2008 | Overview Run Time: 00:03:31 |
|
Transcript |
| Full Version Run Time: 00:04:34 |
|
Transcript | ||
| Important Information on the Correct Use of Spiriva and Foradil Capsules | March 3, 2008 | Overview Run Time: 00:02:49 |
|
Transcript |
| Full Version Run Time: 00:03:45 |
|
Transcript | ||
| Important Warnings and Instructions for Heparin Sodium Injection (Baxter) | February 13, 2008 | Overview Run Time: 00:05:15 |
|
Transcript |
| Full Version Run Time: 00:08:03 |
|
Transcript | ||
| Varenicline (marketed as Chantix) | February 1, 2008 | Overview Run Time: 00:03:43 |
|
Transcript |
| Full Version Run Time: 00:04:40 |
|
Transcript | ||
| Use of Over-the-Counter (OTC) Cough and Cold Products in Infants and Children | January 18, 2008 | Overview Run Time: 00:04:09 |
|
Transcript |
| Full Version Run Time: 00:05:05 |
|
Transcript | ||
| Edetate Disodium (marketed as Endrate and generic products) | January 18, 2008 | Overview Run Time: 00:02:33 |
|
Transcript |
| Full Version Run Time: 00:05:54 |
|
Transcript | ||
| Fentanyl Transdermal System (Patch) (marketed as Duragesic and generics) | December 21, 2007 | Overview Run Time: 00:03:05 |
|
Transcript |
| Full Version Run Time: 00:05:20 |
|
Transcript | ||
| Erythropoiesis-Stimulating Agents (ESAs) | November 8, 2007 | Overview Run Time: 00:01:25 |
|
Transcript |
| Full Version Run Time: 00:04:16 |
|
Transcript | ||
| Safe Use of Fentora (fentanyl buccal tablets) | September 27, 2007 | Overview Run Time: 00:02:47 |
|
Transcript |
| Full Version Run Time: 00:04:55 |
|
Transcript | ||
| Codeine Side-Effects in Nursing Infants | August 17, 2007 | Overview Run Time: 00:01:38 |
|
Transcript |
| Full Version Run Time: 00:05:50 |
|
Transcript | ||
| Nonprescription Cough and Cold Medicine Use in Children | August 16, 2007 | Overview Run Time: 00:01:20 |
|
Transcript |
| Full Version Run Time: 00:03:58 |
|
Transcript | ||
| Colistimethate (marketed as Coly-Mycin M and generic products) | June 29, 2007 | Overview Run Time: 00:01:46 |
|
Transcript |
| Full Version Run Time: 00:04:13 |
|
Transcript | ||
| Tegaserod maleate (marketed as Zelnorm) | March 30, 2007 | Overview Run Time: 00:01:39 |
|
Transcript |
| Full Version Run Time: 00:04:57 |
|
Transcript | ||
| Pergolide (marketed as Permax) | March 29, 2007 | Overview Run Time: 00:01:44 |
|
Transcript |
| Full Version Run Time: 00:05:43 |
|
Transcript | ||
| Erythropoiesis Stimulating Agents (ESAs) | March 13, 2007 | Overview Run Time: 00:02:18 |
|
Transcript |
| Full Version Run Time: 00:06:32 |
|
Transcript | ||
| Interferon gamma-1b (marketed as Actimmune) | March 13, 2007 | Overview Run Time: 00:01:34 |
|
Transcript |
| Full Version Run Time: 00:03:17 |
|
Transcript | ||
| Topical Anesthetics | February 6, 2007 | Overview Run Time: 00:01:51 |
|
Transcript |
| Full Version Run Time: 00:07:00 |
|
Transcript | ||
| Welcome from Dr. von Eschenbach | February 6, 2007 | Full Version Run Time: 00:02:12 |
|
Transcript |
-
-